In focus · trending topic

RAFA Pharmaceuticals

3 stories · following the connections

AXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THC

By Nasdaq OMXNov 29, 2016, 2:01 PM UTC

AXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THC

By Nasdaq OMXNov 29, 2016, 2:01 PM UTC

AXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa Pharmaceuticals

By Nasdaq OMXSep 19, 2016, 1:00 PM UTC